Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Illumina: Grail's Divestment Could Unlock Significant Shareholder Value
02:16pm, Tuesday, 12'th Dec 2023
Illumina's market cap has fallen 80% from its all-time highs in 2021, but the divestment of Grail could bring it back on track. Illumina's competitive advantage lies in its scalable DNA sequencing pla
Illumina's fight with EU regulators over $7.1B Grail acquisition rages on
11:26am, Tuesday, 12'th Dec 2023
Illumina Inc (NASDAQ:ILMN), a genetic testing company, accused European Union antitrust1B regulators of overreach in their decision to stop its $7.1 billion acquisition of cancer detection test comp
Illumina files registration statement for potential Grail divestiture
01:40pm, Monday, 11'th Dec 2023
Illumina said on Monday it had filed a registration statement with the U.S. securities regulator related to a potential divestiture of Grail , even as it challenges a European Union order to divest th
Illumina (ILMN) Expands Globally Despite Macroeconomic Woes
10:32am, Monday, 11'th Dec 2023
The NovaSeq X launch strengthens Illumina's (ILMN) competitive position in high-throughput sequencing.
Illumina, Inc. (ILMN) Piper Sandler 35th Annual Healthcare Conference (Transcript)
07:18pm, Wednesday, 29'th Nov 2023
Illumina, Inc. (NASDAQ:ILMN ) Piper Sandler 35th Annual Healthcare Conference November 29, 2023 11:30 AM ET Company Participants Jacob Thaysen - Chief Executive Officer Conference Call Participants Da
Illumina, Inc. (ILMN) Evercore ISI 6th Annual HealthCONx Conference
02:40pm, Tuesday, 28'th Nov 2023
Illumina, Inc. (NASDAQ:ILMN ) Evercore ISI 6th Annual HealthCONx Conference November 28, 2023 10:50 AM ET Company Participants Joydeep Goswami - Chief Financial Officer Salli Schwartz - Vice President
Illumina (ILMN) Launches Initiative on Pathogen Sequencing
08:16am, Thursday, 16'th Nov 2023
Illumina (ILMN) introduces a new initiative to drive more equitable access to genomics globally.
As Illumina stock bounces off a 10-year low, analysts see no quick fix
10:41am, Tuesday, 14'th Nov 2023
As shares of Illumina Inc. ILMN, +5.46% trade near 10-year lows, analysts are reining in expectations for the DNA-sequencing company.
LGND or ILMN: Which Is the Better Value Stock Right Now?
12:47pm, Monday, 13'th Nov 2023
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Ligand Pharmaceuticals (LGND) or Illumina (ILMN). But which of these two stocks offers value
Illumina Shares Hit a 10-Year Low as the Company's Customers Pull Back on Spending
04:00pm, Friday, 10'th Nov 2023
Illumina (ILMN) shares fell to their lowest level in a decade after the genetic research equipment manufacturer missed revenue estimates and slashed its guidance as customers pulled back on spending.
Midday Movers: Hologic and Meta Platforms Gain, Illumina Sinks
12:30pm, Friday, 10'th Nov 2023
U.S. equities gained at midday after yesterday's selloff snapped long winning streaks for the S&P 500 and Nasdaq. Bond yields were lower after jumping yesterday when Fed Chair Jerome Powell suggested
Illumina's stock on track for lowest close in 10 years after cutting guidance
10:16am, Friday, 10'th Nov 2023
Illumina Inc.'s stock ILMN, -13.91% fell 14% Friday to put it on track for its lowest close in 10 years, after the company after the maker of DNA-sequencing technology cut its full-year sales and prof
Illumina stock drops on another earnings warning
09:21am, Friday, 10'th Nov 2023
Illumina Inc (NASDAQ:ILMN) shares sank 11% in pre-market trading on Friday after the gene-testing company reduced its annual profit forecast for the second straight quarter, citing weakness in demand
Illumina (ILMN) Q3 Earnings Surpass Estimates, '23 View Cut
09:01am, Friday, 10'th Nov 2023
Illumina (ILMN) reports solid earnings in the third quarter of 2023 amid a challenging macro environment.
Illumina, Inc. (ILMN) Q3 2023 Earnings Call Transcript
07:43pm, Thursday, 09'th Nov 2023
Illumina, Inc. (NASDAQ:ILMN ) Q4 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Salli Schwartz - Vice President of Investor Relations Jacob Thaysen - Chief Executive Of
